Stocks Inch Higher After Indexes Post Worst Week of 2023,A rebound in the shares...
Biotechnology Services
Opinion | No Country for Alzheimer’s Patients,Biden’s CMS refuses Medicare coverage despite evidence of...
WSJ News Exclusive | Pfizer in Talks to Acquire Seagen in Deal Likely Valued...
Opinion | The FTC’s Antitrust Collusion,Emails suggest the agency is working with foreign regulators...
Moderna Peers Over a Scary Profit Cliff,The vaccine maker’s profits will drop sharply this...
Opinion | The FDA Returns to Its Bad Habits,The agency may nix a new...
